SciELO - Scientific Electronic Library Online

 
vol.40 número3Importancia de la determinación de homocisteinemia y metilentetrahidrofolato reductasa C677TTécnicas para determinación cuali/cuantitativa de drogas de abuso en fluidos biológicos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

Compartir


Acta bioquímica clínica latinoamericana

versión impresa ISSN 0325-2957versión On-line ISSN 1851-6114

Resumen

LARREGINA, Alejandra et al. Molecular diagnostic of prothrombotic risk factors in dialysed patients. Acta bioquím. clín. latinoam. [online]. 2006, vol.40, n.3, pp.341-345. ISSN 0325-2957.

Thromboembolic disease is a multifactorial disorder that results from existing relations between acquired and genetic factors. Hypercoagulation states or thrombophilia increase the risk of thrombosis development. The aim of this study was to evaluate the occurrence of three prothrombotic risk factors: factor V Leiden, prothrombin 20210 and methylenetetrahydrofolate reductase thermolability in 100 chronic hemodialysed patients, 29 women and 71 men. Point mutation study showed that one patient was homozygote for factor V Leiden, another was heterozygote for prothrombin 20210, and finally 14 patients presented mutated methylenetetrahydrofolate reductase thermolability, 6 homozygote and 8 heterozygote. Those findings must be kept in mind when anticoagulant treatment is indicated to those patients having venous access danger, considering their best quality of life.

Palabras clave : prothrombotic risk factors; chronic hemodialysed patients.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons